Skip to main content
Equibles

XTX Topco Ltd

Position in NTLA — Intellia Therapeutics, Inc.

CIK 1828301 LONDON, X0
Back to NTLA Full portfolio

Position in NTLA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,408,297
+$2,716,248 QoQ
Shares Held
201,436
+273.2% QoQ
Ownership
0.144%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#69
of 330 holders
Holding Since
Jun 2021
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NTLA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

XTX Topco Ltd holds $414,894,447 across 381 Biotechnology names. NTLA ranks #31 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 30,522 $19,031,687
2 ASND
Ascendis Pharma A/S
 43,289 $11,546,042
3 BBIO
BridgeBio Pharma, Inc.
 116,611 $8,685,187
4 MRNA
Moderna, Inc.
 123,281 $8,633,368
5 JAZZ
Jazz Pharmaceuticals plc
 30,496 $7,348,621
6 KYMR
Kymera Therapeutics, Inc.
 61,501 $7,052,319
7 CYTK
Cytokinetics Inc
 80,743 $6,878,496
8 PTCT
Ptc Therapeutics, Inc.
 81,923 $6,682,459

All Filings in NTLA

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,408,297 201,436
2026-03-31 $692,049 53,982
2025-12-31 $402,419 44,763
2025-06-30 $390,573 41,639
2025-03-31 $575,177 80,897
2024-12-31 $511,967 43,908
2024-09-30 $306,236 14,902
2024-06-30 $1,129,384 50,464
2024-03-31 $502,415 18,263
2023-12-31 $384,814 12,621
2023-09-30 $470,379 14,876
2023-03-31 $494,125 13,258
2022-12-31 $460,652 13,203
2022-09-30 $638,335 11,407
2021-06-30 $447,195 2,762